Sponsor:
Ohio State University Comprehensive Cancer Center
Code:
NCT02560883
Conditions
Leukemia, Other
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Leukemia, Other
Study ID
NCT02560883
Start date
Jan 2, 2013
Status verified date
Jun, 2026
Completion date
Dec 31, 2030
Anticipated
Primary completion date
Dec 31, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
5000 participants
Anticipated
Primary outcome measure
Central contacts
Elena Botoulas, BS
614-685-0635Locations
University of Miami/Soffer Clinical Research Center
Recruiting
Miami, Florida, United States, 33136
Contacts
Principal Investigator:
Justin Taylor, M.D.
Mount Sinai Medical Center of Florida
Recruiting
Miami Beach, Florida, United States, 33140
Contacts
Mayo Clinic
Recruiting
Rochester, Minnesota, United States, 55905
Contacts
Principal Investigator:
Sameer Parikh, MD
University of Rochester /Wilmot Cancer Institute
Recruiting
Rochester, New York, United States, 14642
Contacts
Principal Investigator:
Clive Zent, MD
Ohio State University Comprehensive Cancer Center
Recruiting
Columbus, Ohio, United States, 43210
Contacts
Principal Investigator:
Michael Grever, MD
BC Cancer, Part of the Provincial Health Services Authority
Recruiting
Vancouver, Britsh Columbia, Canada, V5Z 4E6
Contacts
Cancer Care Manitoba
Recruiting
Winnipeg, Manitoba, Canada, R3E 0V9
Contacts
Principal Investigator:
Banerji Banerji, MD
Sponsor
Ohio State University Comprehensive Cancer Center
Last update posted
Jul 2, 2026
Last verified
Jun, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Ohio State University Comprehensive Cancer Center on 2026-07-02.